The Recurrence Rates at Three Years for the Conservatively Managed UTUC Cases Using NBI-Assisted Flexible Ureteroscopy and Holmium Laser Vaporization

<i>Background and Objectives</i>: This study aimed to evaluate the recurrence rates at three years for upper tract urothelial carcinoma (UTUC) cases managed conservatively, using Narrow Band Imaging (NBI)-assisted flexible ureteroscopy and Holmium laser vaporization. <i>Materials a...

Full description

Saved in:
Bibliographic Details
Main Authors: Petrisor Geavlete, Valentin Iordache, Razvan Multescu, Alexandra Paunescu, Cosmin Ene, Razvan Popescu, Catalin Bulai, Bogdan Geavlete
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/60/12/1911
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850084961394098176
author Petrisor Geavlete
Valentin Iordache
Razvan Multescu
Alexandra Paunescu
Cosmin Ene
Razvan Popescu
Catalin Bulai
Bogdan Geavlete
author_facet Petrisor Geavlete
Valentin Iordache
Razvan Multescu
Alexandra Paunescu
Cosmin Ene
Razvan Popescu
Catalin Bulai
Bogdan Geavlete
author_sort Petrisor Geavlete
collection DOAJ
description <i>Background and Objectives</i>: This study aimed to evaluate the recurrence rates at three years for upper tract urothelial carcinoma (UTUC) cases managed conservatively, using Narrow Band Imaging (NBI)-assisted flexible ureteroscopy and Holmium laser vaporization. <i>Materials and Methods</i>: The study group included 61 patients who were diagnosed with NBI-assisted visualization with superficial pyelo-calyceal urothelial tumor lesions, treated conservatively by the flexible ureteroscopic approach and Holmium laser vaporization, also assisted by NBI. This was compared with a control group with the same number of cases, which underwent the same procedure, but without NBI technology. Recurrence rates, the rate of patients who underwent nephroureterectomy, and cancer-specific survival were compared. <i>Results</i>: The relapse rate at 1 year was 3.3% in the study group, and respectively 8.2% in the control group (<i>p</i> < 0.05). Depending on the histological characteristics, at 1 year the relapse rates in the study group were 1.8% in patients with low-grade tumors and 20% in those with high-grade tumors. At 3 years, the relapse rate was 11.5% in the study group versus 18% in the control group, (<i>p</i> < 0.05): 7.1% in patients with low-grade lesions and 40% in patients with high-grade lesions versus 21.4% in patients with low-grade lesions and 100% in patients with high-grade lesions (both arms with statistically significant differences, <i>p</i> < 0.05). Cancer-specific survival was 93.4% in the study group versus 86.9% in the control group (<i>p</i> < 0.05). <i>Conclusions</i>: The recurrence rates at three years for the UTUC cases managed conservatively, using NBI-assisted flexible ureteroscopy and Holmium laser vaporization, were lower than in patients treated by the same technique without NBI assistance, both in low- and high-grade tumors. Cancer-specific survival was also significantly improved by the association of NBI visualization during diagnosis and laser vaporization.
format Article
id doaj-art-da5bf338b65b404fbe14f20e16c9f23a
institution DOAJ
issn 1010-660X
1648-9144
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj-art-da5bf338b65b404fbe14f20e16c9f23a2025-08-20T02:43:50ZengMDPI AGMedicina1010-660X1648-91442024-11-016012191110.3390/medicina60121911The Recurrence Rates at Three Years for the Conservatively Managed UTUC Cases Using NBI-Assisted Flexible Ureteroscopy and Holmium Laser VaporizationPetrisor Geavlete0Valentin Iordache1Razvan Multescu2Alexandra Paunescu3Cosmin Ene4Razvan Popescu5Catalin Bulai6Bogdan Geavlete7Department of Urology, “St. John” Emergency Clinical Hospital, Vitan-Barzesti 13, District 4, 042122 Bucharest, RomaniaDepartment of Urology, “St. John” Emergency Clinical Hospital, Vitan-Barzesti 13, District 4, 042122 Bucharest, RomaniaDepartment of Urology, “St. John” Emergency Clinical Hospital, Vitan-Barzesti 13, District 4, 042122 Bucharest, RomaniaDepartment of Pathology, “St. John” Emergency Clinical Hospital, Vitan-Barzesti 13, District 4, 042122 Bucharest, RomaniaDepartment of Urology, “St. John” Emergency Clinical Hospital, Vitan-Barzesti 13, District 4, 042122 Bucharest, RomaniaFaculty of General Medicine, “Carol Davila” University of Medicine and Pharmacy, Dionisie Lupu Street 37, District 1, 030167 Bucharest, RomaniaDepartment of Urology, “St. John” Emergency Clinical Hospital, Vitan-Barzesti 13, District 4, 042122 Bucharest, RomaniaDepartment of Urology, “St. John” Emergency Clinical Hospital, Vitan-Barzesti 13, District 4, 042122 Bucharest, Romania<i>Background and Objectives</i>: This study aimed to evaluate the recurrence rates at three years for upper tract urothelial carcinoma (UTUC) cases managed conservatively, using Narrow Band Imaging (NBI)-assisted flexible ureteroscopy and Holmium laser vaporization. <i>Materials and Methods</i>: The study group included 61 patients who were diagnosed with NBI-assisted visualization with superficial pyelo-calyceal urothelial tumor lesions, treated conservatively by the flexible ureteroscopic approach and Holmium laser vaporization, also assisted by NBI. This was compared with a control group with the same number of cases, which underwent the same procedure, but without NBI technology. Recurrence rates, the rate of patients who underwent nephroureterectomy, and cancer-specific survival were compared. <i>Results</i>: The relapse rate at 1 year was 3.3% in the study group, and respectively 8.2% in the control group (<i>p</i> < 0.05). Depending on the histological characteristics, at 1 year the relapse rates in the study group were 1.8% in patients with low-grade tumors and 20% in those with high-grade tumors. At 3 years, the relapse rate was 11.5% in the study group versus 18% in the control group, (<i>p</i> < 0.05): 7.1% in patients with low-grade lesions and 40% in patients with high-grade lesions versus 21.4% in patients with low-grade lesions and 100% in patients with high-grade lesions (both arms with statistically significant differences, <i>p</i> < 0.05). Cancer-specific survival was 93.4% in the study group versus 86.9% in the control group (<i>p</i> < 0.05). <i>Conclusions</i>: The recurrence rates at three years for the UTUC cases managed conservatively, using NBI-assisted flexible ureteroscopy and Holmium laser vaporization, were lower than in patients treated by the same technique without NBI assistance, both in low- and high-grade tumors. Cancer-specific survival was also significantly improved by the association of NBI visualization during diagnosis and laser vaporization.https://www.mdpi.com/1648-9144/60/12/1911UTUC recurrenceflexible ureteroscopyHolmium laserNBI
spellingShingle Petrisor Geavlete
Valentin Iordache
Razvan Multescu
Alexandra Paunescu
Cosmin Ene
Razvan Popescu
Catalin Bulai
Bogdan Geavlete
The Recurrence Rates at Three Years for the Conservatively Managed UTUC Cases Using NBI-Assisted Flexible Ureteroscopy and Holmium Laser Vaporization
Medicina
UTUC recurrence
flexible ureteroscopy
Holmium laser
NBI
title The Recurrence Rates at Three Years for the Conservatively Managed UTUC Cases Using NBI-Assisted Flexible Ureteroscopy and Holmium Laser Vaporization
title_full The Recurrence Rates at Three Years for the Conservatively Managed UTUC Cases Using NBI-Assisted Flexible Ureteroscopy and Holmium Laser Vaporization
title_fullStr The Recurrence Rates at Three Years for the Conservatively Managed UTUC Cases Using NBI-Assisted Flexible Ureteroscopy and Holmium Laser Vaporization
title_full_unstemmed The Recurrence Rates at Three Years for the Conservatively Managed UTUC Cases Using NBI-Assisted Flexible Ureteroscopy and Holmium Laser Vaporization
title_short The Recurrence Rates at Three Years for the Conservatively Managed UTUC Cases Using NBI-Assisted Flexible Ureteroscopy and Holmium Laser Vaporization
title_sort recurrence rates at three years for the conservatively managed utuc cases using nbi assisted flexible ureteroscopy and holmium laser vaporization
topic UTUC recurrence
flexible ureteroscopy
Holmium laser
NBI
url https://www.mdpi.com/1648-9144/60/12/1911
work_keys_str_mv AT petrisorgeavlete therecurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT valentiniordache therecurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT razvanmultescu therecurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT alexandrapaunescu therecurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT cosminene therecurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT razvanpopescu therecurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT catalinbulai therecurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT bogdangeavlete therecurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT petrisorgeavlete recurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT valentiniordache recurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT razvanmultescu recurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT alexandrapaunescu recurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT cosminene recurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT razvanpopescu recurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT catalinbulai recurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization
AT bogdangeavlete recurrenceratesatthreeyearsfortheconservativelymanagedutuccasesusingnbiassistedflexibleureteroscopyandholmiumlaservaporization